TScan Therapeutics Inc. (TCRX)
Market Closed
27 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 77
-0.03
-3.2368%
$
54.95M Market Cap
- P/E Ratio
- Div Yield
902,032 Volume
-1.04 Eps
$ 0.79
Previous Close 
Want to track TCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TScan Therapeutics Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 David Nierengarten Wedbush | 54,288.82 | $50,000 | $50,738.33 | $738.33 | 1.48% |
